A Johnson & Johnson medical device company, DePuy Synthes, has announced the introduction of its rotating platform option for the Attune Cementless Knee in select markets across the globe.
Set to launch in the US, a number of countries in Europe, Japan, Australia, and New Zealand, the rotating platform option comes as part of DePuy’s comprehensive Attune Knee platform, which favours the cementless replacement for younger and more active patients to suit their current and future lifestyles.
An associate professor and fellowship director at Washington University Orthopaedics, Ryan M. Nunley, remarked: “I feel the cementless technology is a better alternative for my younger and more active patients who have healthy, strong bone. These patients have the potential to remain active for many decades, and I think the evidence is growing that cementless knees have good long-term durability.”
The device uses a handful of patented technologies which aim to boost and improve knee function through increased stability and range of motion.
Vice president of DePuy Synthes EMEA Joint Reconstruction, Torbjorn Sköld, said: “With the Attune Cementless Knee, we have carried forward technologies and learnings from clinically proven devices like the LCS Knee and combined that with Attune Knee patented technologies to provide our customers a compelling solution to meeting emerging patient needs. Our strong hope and belief is that this implant system will help younger, more active patients get back to doing what they love if their surgeon feels they are the right candidate.”